Ultragenyx Pharmaceutical Inc. (RARE) stock
RARENasdaqPharmaceutical PreparationsFiscal year ends December 31
$17.73+1.03 (+6.17%)
Close on Nov 18, 2026Market cap $1.75BP/E –Yield –
Ultragenyx Pharmaceutical market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Ultragenyx Pharmaceutical's market cap was $1.65B on Nov 11, 2026, against $3.35B a year earlier. Over the last 5 years it ranged from $1.48B to $5.71B, with a median of $3.27B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $1.65B | -25.8% |
| 2025 | Dec 31, 2025 | $2.22B | -42.9% |
| 2024 | Dec 31, 2024 | $3.88B | +12.5% |
| 2023 | Dec 29, 2023 | $3.45B | +6.3% |
| 2022 | Dec 30, 2022 | $3.25B | -43.2% |
| 2021 | Dec 31, 2021 | $5.71B | -32.1% |
| 2020 | Dec 31, 2020 | $8.42B | +241.3% |
| 2019 | Dec 31, 2019 | $2.47B | +12.3% |
| 2018 | Dec 31, 2018 | $2.20B | +11.5% |
| 2017 | Dec 29, 2017 | $1.97B | -30.0% |
| 2016 | Dec 30, 2016 | $2.82B | -35.3% |
| 2015 | Dec 31, 2015 | $4.36B | +211.7% |
| 2014 | Dec 31, 2014 | $1.40B | – |
See a number that looks wrong?